The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...

The team’s study results, published today in the journal Immunity, outline their discovery of a specific type of regulatory T cell that can home back into the thymus and repair the organ when it ...

“Our discovery—the regulatory T cell recirculation back to the thymus—promotes repair through a process that hasn’t been described before and represents a novel pathway to regeneration ...

An enhanced CT scan of the thymus showed a mass-like soft tissue density in the ... Consensus Guidance for Management (5), the final diagnosis was MG with Myasthenia Gravis Foundation of America (MGFA ...

There have been great advances in the field of generalised myasthenia gravis (gMG) in recent years, but many patients remain dissatisfied with their disease state despite being on treatment. There is ...

Eculizumab effectively reduced MG-ADL scores and corticosteroid use in thymoma-associated myasthenia gravis patients by week 12. The monoclonal antibody targets complement protein C5, preventing ...

A patient with thymoma-associated myasthenia gravis (MG) was successfully treated with ravulizumab as described in a case study published in Muscle & Nerve. The 39-year-old female patient was ...

Cancer that starts in the thymus gland is called thymus cancer. It starts when cells in the thymus gland grow out of control and crowd out normal cells. Thymus cancers are rare. The thymus is a small ...